AZOPT

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug AZOPT contains one active pharmaceutical ingredient (API):

1	Brinzolamide UNII 9451Z89515 - BRINZOLAMIDE
	Brinzolamide is an inhibitor of carbonic anhydrase II (CA-II). Carbonic anhydrase (CA) is an enzyme found in many tissues of the body, including the eye. Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humour secretion resulting in a reduction in intraocular pressure (IOP) which is a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual field loss.
	Read more about Brinzolamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AZOPT Eye drops, suspension	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01EC04	Brinzolamide	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EC Carbonic anhydrase inhibitors
Discover more medicines within S01EC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5540N, 8483L
BR	Câmara de Regulação do Mercado de Medicamentos	500900401178310
CA	Health Products and Food Branch	02238873
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00432768, 00587666, 00587672, 00698130, 02477373, 02477396, 03963124, 04649306, 05026990, 05027050, 05485048, 05485054, 06455552, 06455569, 06920279, 09671546, 10297604, 11613970, 11730463, 12500297, 17277875, 17558491
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	26.185-02-05
EE	Ravimiamet	1042782, 1213074, 1213085
ES	Centro de información online de medicamentos de la AEMPS	00129001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	566182
FR	Base de données publique des médicaments	60868670
GB	Medicines & Healthcare Products Regulatory Agency	138440, 14038, 374305
HK	Department of Health Drug Office	49989
IE	Health Products Regulatory Authority	50701, 50724, 50789, 50808, 50816
IT	Agenzia del Farmaco	034770014
JP	医薬品医療機器総合機構	1319748Q1036
LT	Valstybinė vaistų kontrolės tarnyba	1003697, 1027610, 1027611
NG	Registered Drug Product Database	04-6817
Switch country to Nigeria in order to find specific presentations of AZOPT
NL	Z-Index G-Standaard	14656612
NL	Z-Index G-Standaard, PRK	72877
NZ	Medicines and Medical Devices Safety Authority	8931
PL	Rejestru Produktów Leczniczych	100100945
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64500001, W64500002, W64500003
SG	Health Sciences Authority	11029P
TN	Direction de la Pharmacie et du Médicament	20833011
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504710113
US	FDA, National Drug Code	0065-0275